Revvity (NYSE:RVTY) Reaches New 52-Week High – Time to Buy?

Shares of Revvity Inc. (NYSE:RVTY) reached a new 52-week high on Wednesday . The stock traded as high as $120.77 and last traded at $120.83, with a volume of 115795 shares traded. The stock had previously closed at $113.75.

Analysts Set New Price Targets

A number of research firms recently issued reports on RVTY. Zacks Research upgraded Revvity from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. JPMorgan Chase & Co. cut their target price on Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Robert W. Baird set a $117.00 price target on Revvity in a research report on Wednesday, May 6th. Weiss Ratings raised shares of Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. Finally, Evercore reiterated an “outperform” rating on shares of Revvity in a report on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $108.36.

Revvity Price Performance

The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. The company has a fifty day moving average price of $110.13 and a two-hundred day moving average price of $100.02. The company has a market cap of $13.44 billion, a P/E ratio of 57.46, a PEG ratio of 2.13 and a beta of 1.07.

Revvity (NYSE:RVTY) last released its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.20. The business had revenue of $729.69 million for the quarter, compared to analyst estimates of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.Revvity’s revenue was down 1.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, sell-side analysts anticipate that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. Revvity’s dividend payout ratio is currently 13.33%.

Hedge Funds Weigh In On Revvity

Hedge funds and other institutional investors have recently made changes to their positions in the company. Ascentis Independent Advisors bought a new position in shares of Revvity in the 1st quarter valued at about $29,000. CYBER HORNET ETFs LLC bought a new stake in Revvity in the 2nd quarter valued at $32,000. MUFG Securities EMEA plc acquired a new stake in Revvity during the 2nd quarter valued at $34,000. SJS Investment Consulting Inc. lifted its stake in shares of Revvity by 5,210.0% during the 1st quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock worth $47,000 after buying an additional 521 shares during the last quarter. Finally, Headlands Technologies LLC bought a new stake in shares of Revvity during the second quarter worth approximately $49,000. 86.65% of the stock is owned by institutional investors.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.